Potential impact of nicorandil on the pharmacodynamics of anti-angiogenic agents
Abstract Anti-angiogenic agents are widely used to treat solid tumors. We previously demonstrated that nicorandil, an angina pectoris medication, counteracted the effects of bevacizumab in a human mini-tumor model. To further elucidate the potential pharmacodynamic interactions and possible clinical...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Portfolio
2026-03-01
|
| Serie: | Scientific Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1038/s41598-026-37059-z |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|